Shengchun Liu

2.6k total citations
103 papers, 1.9k citations indexed

About

Shengchun Liu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Shengchun Liu has authored 103 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 46 papers in Molecular Biology and 39 papers in Cancer Research. Recurrent topics in Shengchun Liu's work include Breast Cancer Treatment Studies (17 papers), Ferroptosis and cancer prognosis (15 papers) and RNA modifications and cancer (11 papers). Shengchun Liu is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), Ferroptosis and cancer prognosis (15 papers) and RNA modifications and cancer (11 papers). Shengchun Liu collaborates with scholars based in China, Canada and United States. Shengchun Liu's co-authors include Weihong Song, Fang Cai, Weihui Zhou, Yang Peng, Haochen Yu, Masahide Tone, Yu Deng, Yukiko Tone, Yigang Tong and Chia-Hsiung Chen and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

In The Last Decade

Shengchun Liu

98 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengchun Liu China 22 901 613 569 383 248 103 1.9k
Andelko Hrzenjak Austria 32 1.4k 1.5× 604 1.0× 374 0.7× 326 0.9× 205 0.8× 63 2.5k
Rossano Lattanzio Italy 29 1.3k 1.4× 436 0.7× 959 1.7× 290 0.8× 369 1.5× 83 2.7k
Tatsuki Itoh Japan 32 1.1k 1.2× 532 0.9× 670 1.2× 290 0.8× 133 0.5× 81 2.4k
Xiuling Zhi China 27 1.1k 1.2× 399 0.7× 509 0.9× 192 0.5× 170 0.7× 63 2.3k
Yi Luo China 24 895 1.0× 499 0.8× 273 0.5× 214 0.6× 171 0.7× 75 1.7k
George Kulik United States 22 1.7k 1.9× 442 0.7× 568 1.0× 321 0.8× 133 0.5× 38 2.7k
HyeSook Youn South Korea 30 1.4k 1.6× 725 1.2× 469 0.8× 331 0.9× 124 0.5× 70 2.4k
Chunyan Zhang China 22 1.5k 1.7× 1.3k 2.1× 489 0.9× 224 0.6× 124 0.5× 70 2.3k
Lin Lin China 28 1.4k 1.6× 1.2k 1.9× 323 0.6× 177 0.5× 286 1.2× 100 2.4k

Countries citing papers authored by Shengchun Liu

Since Specialization
Citations

This map shows the geographic impact of Shengchun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengchun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengchun Liu more than expected).

Fields of papers citing papers by Shengchun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengchun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengchun Liu. The network helps show where Shengchun Liu may publish in the future.

Co-authorship network of co-authors of Shengchun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengchun Liu. A scholar is included among the top collaborators of Shengchun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengchun Liu. Shengchun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Meiying, Yanan Hao, Bozhi Wang, et al.. (2025). Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRASG12V neoantigen without cross-recognition of the self-antigen RAB7B in solid tumors. Journal for ImmunoTherapy of Cancer. 13(7). e011863–e011863. 1 indexed citations
2.
Han, Xiaojian, Yanan Hao, Bozhi Wang, et al.. (2025). Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognition. Journal of Translational Medicine. 23(1). 78–78. 3 indexed citations
3.
Liu, Shengchun, et al.. (2024). USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(3). 167011–167011. 7 indexed citations
6.
Shu, Dan, Han Li, Wenjie Zhang, et al.. (2024). SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2− breast cancer. Cell Death and Disease. 15(6). 444–444. 7 indexed citations
7.
8.
Liu, Yang, Shengchun Liu, Zhili Sun, et al.. (2023). Study on disinfection effect of a 222-nm UVC excimer lamp on object surface. AMB Express. 13(1). 102–102. 7 indexed citations
9.
Wang, Yuan, et al.. (2023). An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer. Journal of Personalized Medicine. 13(3). 513–513. 5 indexed citations
10.
Tang, Zhenrong, et al.. (2023). Characterization of starvation response‐related genes for predicting prognosis in breast cancer. Cancer Science. 114(8). 3144–3161. 1 indexed citations
11.
Tang, Zhenrong, et al.. (2022). Study of the Antimicrobial Activity of the Chinese Dong Ethnic Minority Medicine, Madeng’ai. Evidence-based Complementary and Alternative Medicine. 2022. 1–8. 2 indexed citations
12.
Xu, Yingkun, Han Li, Zhenrong Tang, et al.. (2022). Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients. Journal of Oncology. 2022. 1–15. 17 indexed citations
13.
Xu, Yingkun, Dan Shu, Meiying Shen, et al.. (2022). Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer. Journal of Immunology Research. 2022. 1–22. 9 indexed citations
14.
Tang, Zhenrong, et al.. (2022). Comprehensive Analysis of Necroptosis-Related Genes as Prognostic Factors and Immunological Biomarkers in Breast Cancer. Journal of Personalized Medicine. 13(1). 44–44. 4 indexed citations
15.
Tian, Jiao, Zhenrong Tang, Yu Wang, et al.. (2020). Prognostic value of programmed cell death ligand-1 expression in breast cancer. Medicine. 99(49). e23359–e23359. 6 indexed citations
16.
Qu, Fanli, Rui Chen, Yang Peng, et al.. (2020). Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Journal of Breast Cancer. 23(3). 246–246. 8 indexed citations
17.
Yang, Tiantian, Lulu Xu, Shengchun Liu, et al.. (2019). Amplified fluorescence imaging of HER2 dimerization on cancer cells by using a co-localization triggered DNA nanoassembly. Microchimica Acta. 186(7). 439–439. 10 indexed citations
19.
Liu, Shengchun, et al.. (2010). Experiment of no-row corn harvesting device with finger wheel.. Nongye gongcheng xuebao. 26(5). 103–106. 1 indexed citations
20.
Cai, Fang, Bin Chen, Weihui Zhou, et al.. (2007). SP1 regulates a human SNAP‐25 gene expression. Journal of Neurochemistry. 105(2). 512–523. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026